BeOne Medicines AG (ONC)
NASDAQ: ONC · Real-Time Price · USD
411.29
-5.25 (-1.26%)
Nov 16, 2026, 4:00 PM EST - Market closed

BeOne Medicines AG Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
42,82936,94527,58715,5289,7667,472
Other Revenue
408.99426.46224.051,907--
43,23837,37127,81117,4359,7667,472
Revenue Growth
22.14%34.37%59.51%78.53%30.69%270.56%
Cost of Revenue
4,4074,6764,3362,6941,9761,048
Gross Profit
38,83132,69523,47514,7417,7906,425
Selling, General & Admin
14,70714,55913,36510,6938,8196,290
Research & Development
15,57615,00914,25712,61211,3159,270
Amortization of Goodwill & Intangibles
-----4.76
Operating Expenses
30,35929,56827,62223,30520,13415,565
Operating Income
8,4723,127-4,147-8,564-12,344-9,140
Interest Expense
-390.62-407.31-159.16-30.94-131.77-179.2
Interest & Investment Income
847.86493.14508.32555.74493.7479.1
Earnings From Equity Investments
-100.5-104.79-75-55.71-25.4-11.41
Other Non Operating Income (Expenses)
-143.94223.5647.74-285.74-1,34652.82
EBT Excluding Unusual Items
8,6853,332-3,825-8,381-13,353-9,198
Gain (Loss) on Sale of Investments
-378.48-416.4-64.98-48.74-172.6959.63
Gain (Loss) on Sale of Assets
0.75-----
Other Unusual Items
---2,573--
Pretax Income
8,2982,916-3,890-5,856-13,526-9,139
Income Tax Expense
1,457908.72815.93396.18295.05122.15
Earnings From Continuing Operations
6,8412,007-4,706-6,252-13,821-9,261
Net Income
6,8412,007-4,706-6,252-13,821-9,261
Net Income to Common
6,8412,007-4,706-6,252-13,821-9,261
Net Income Growth
1301.83%-----
Shares Outstanding (Basic)
11210910510410393
Shares Outstanding (Diluted)
11711310510410393
Shares Change
4.74%7.75%0.86%1.22%11.15%11.16%
EPS (Basic)
61.1218.40-44.70-59.89-134.01-99.81
EPS (Diluted)
58.3017.28-44.70-59.92-134.01-99.81
EPS Growth
1269.44%-----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
9,9506,587-4,622-12,192-12,567-9,921
Free Cash Flow Per Share
85.3558.06-43.90-116.79-121.85-106.92
Gross Margin
89.81%87.49%84.41%84.55%79.77%85.98%
Operating Margin
19.60%8.37%-14.91%-49.12%-126.40%-122.31%
Profit Margin
15.82%5.37%-16.92%-35.86%-141.52%-123.93%
Free Cash Flow Margin
23.01%17.63%-16.62%-69.93%-128.68%-132.76%
EBITDA
9,4394,048-2,928-7,969-11,909-8,851
EBITDA Margin
21.83%10.83%-10.53%-45.71%-121.94%-118.44%
D&A For EBITDA
966.84921.041,219595.18434.89288.99
EBIT
8,4723,127-4,147-8,564-12,344-9,140
EBIT Margin
19.60%8.37%-14.91%-49.12%-126.40%-122.31%
Effective Tax Rate
17.55%31.17%----
Revenue as Reported
35,84037,37127,81117,4359,7667,472
SEC Filings: 10-K · 10-Q